Saracatinib, a Selective Src Kinase Inhibitor, Blocks Fibrotic Responses in Preclinical Models of Pulmonary Fibrosis is a research paper published in American Journal of Respiratory and Critical Care Medicine (2022). On theSindex it has a DataRank of 0.718. It has been cited 119 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.718
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →National Center for Advancing Translational Sciences
Grant: UG3TR002445
National Institutes of Health
Grant: R01HL127349
National Institutes of Health
Grant: U01HL145567
National Institutes of Health
Grant: U01HL122626
National Institutes of Health
Grant: U54HG008540
NHLBI NIH HHS
Grant: R01 HL132950
NCATS NIH HHS
Grant: UL1 TR001863
National Institutes of Health
Grant: 1R01HL132950-01
Checkpoint Function of PTPalpha in Pathological Fibrogenesis in the Lung
National Institutes of Health
Grant: 5U01HL145567-04
Normal Aging Lung Cell Atlas (NALCA)
National Institutes of Health
Grant: 1UG3TR002445-01
Use of the Src Family Kinase Inhibitor Saracatinib in the Treatment of Pulmonary Fibrosis
National Institutes of Health
Grant: 3U54HG008540-02S1
Center for causal Modeling and discovery of Biomedical Knowledge from Big Data
National Institutes of Health
Grant: 5R01HL127349-07
Genomic Analysis of Tissue and Cellular Heterogeneity in IPF
FWCI
14.75
Citation Percentile
1.0%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals